Hims Stock Slips

Morgan Stanley Downgrades Hims & Hers Health (HIMS)
Fintel reports that on February 18, 2025, Morgan Stanley downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 52.37% Downside As of January 30,
HIMS Stock Slips after Catching a Downgrade from Morgan Stanley
Shares of Hims & Hers Health (HIMS) are down at the time of writing after Morgan Stanley, led by four-star analyst Craig Hettenbach,
Morgan Stanley downgrades Hims & Hers on valuation concerns
Morgan Stanley downgraded Hims Hers Health Inc (NYSE:HIMS) to "Equal-weight" from "Overweight" as the stock’s recent strong performance leaves limited near-term upside, despite continued business momentum.
Hims & Hers Health (NYSE:HIMS) Downgraded by Morgan Stanley to Equal Weight
Morgan Stanley cut shares of Hims & Hers Health (NYSE:HIMS – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, MarketBeat.com reports. They currently have $60.
Hims & Hers downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Craig Hettenbach downgraded Hims & Hers to Equal Weight from Overweight with a price target of $60, up from $42. The
Workday slides as Morgan Stanley downgrades amid concerns about top-line growth
Workday (NASDAQ:WDAY) was in focus on Wednesday as Morgan Stanley downgraded the back-office software firm amid concerns that recent investments have failed to spark top-line growth. Shares fell 2.5% in premarket trading.
Morgan Stanley Downgrades Workday (WDAY)
Fintel reports that on February 19, 2025, Morgan Stanley downgraded their outlook for Workday (NasdaqGS:WDAY) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 13.61% Upside As of January 29,
SchaeffersResearch.com2d
Hims and Hers Stock Drops Weight as Earnings Loom
Healthcare stock Hims and Hers (HIMS) is sharply lower today but has contrarian potential next week ahead of earnings ...
Hims & Hers Health (NYSE:HIMS) Sees Large Volume Increase After Analyst Upgrade
Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) saw unusually-high trading volume on Friday after Bank of America raised their price target on the stock from $18.00 to $21.00. Bank of ...
Hosted on MSN1d
Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?
Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. Key Points ...
Seeking Alpha5d
Hims & Hers downgraded at Morgan Stanley on recent rally
Morgan Stanley downgraded telehealth firm Hims & Hers Health (NYSE:HIMS) to Equal Weight from Overweight on Tuesday ahead of its Q4 2024 results next week, citing the stock’s recent rally.
Market Whales and Their Recent Bets on HIMS Options
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...